Hong Yue

847 total citations
28 papers, 638 citations indexed

About

Hong Yue is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hong Yue has authored 28 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Hong Yue's work include Protease and Inhibitor Mechanisms (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Hong Yue is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Hong Yue collaborates with scholars based in United States, China and Japan. Hong Yue's co-authors include Wei Li, Sadashiva S. Karnik, Russell Desnoyer, Hiroyasu Uzui, Takanori Ueda, Jong‐Dae Lee, Wěi Li, Hiromasa Shimizu, Yasuhiko Mitsuke and Hamiyet Ünal and has published in prestigious journals such as Circulation, Nature Communications and Circulation Research.

In The Last Decade

Hong Yue

26 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Yue United States 15 275 141 100 97 91 28 638
Mingming Yang China 17 438 1.6× 180 1.3× 120 1.2× 136 1.4× 137 1.5× 80 966
Marco Benati Italy 15 286 1.0× 221 1.6× 63 0.6× 49 0.5× 50 0.5× 36 697
Michael G. Sugiyama Canada 11 257 0.9× 61 0.4× 61 0.6× 124 1.3× 99 1.1× 20 640
Yanjia Chen China 15 376 1.4× 93 0.7× 144 1.4× 98 1.0× 125 1.4× 37 811
Araceli Páez Mexico 14 187 0.7× 162 1.1× 64 0.6× 116 1.2× 138 1.5× 52 597
Chandrashekhara Manithody United States 22 288 1.0× 221 1.6× 157 1.6× 137 1.4× 143 1.6× 61 1.3k
Sanaz Keshavarz Shahbaz Iran 13 181 0.7× 78 0.6× 47 0.5× 138 1.4× 163 1.8× 32 634
Yijian Li China 14 235 0.9× 175 1.2× 45 0.5× 90 0.9× 71 0.8× 37 566

Countries citing papers authored by Hong Yue

Since Specialization
Citations

This map shows the geographic impact of Hong Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Yue more than expected).

Fields of papers citing papers by Hong Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Yue. The network helps show where Hong Yue may publish in the future.

Co-authorship network of co-authors of Hong Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Yue. A scholar is included among the top collaborators of Hong Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Yue. Hong Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yue, Hong, Fang Bai, Krista L. Denning, et al.. (2024). Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice. Thrombosis Research. 244. 109195–109195. 3 indexed citations
3.
Yue, Hong, et al.. (2023). Thymidine Phosphorylase Deficiency or Inhibition Preserves Cardiac Function in Mice With Acute Myocardial Infarction. Journal of the American Heart Association. 12(7). e028023–e028023. 4 indexed citations
4.
Li, Wei & Hong Yue. (2021). Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner. Frontiers in Medicine. 8. 653773–653773. 9 indexed citations
5.
Yang, Moua, Wei Li, Wenjing Chen, et al.. (2020). Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia. Blood Advances. 4(18). 4494–4507. 26 indexed citations
6.
Chen, Lechuang, Zhimin Feng, Hong Yue, et al.. (2018). Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nature Communications. 9(1). 4585–4585. 67 indexed citations
7.
Feng, Zhimin, Hong Yue, Scott F. Sieg, et al.. (2018). Abstract 5060: Exosomes derived from HIV-infected T cells promote cancer cell growth and progression via the HIV TAR RNA. Cancer Research. 78(13_Supplement). 5060–5060. 3 indexed citations
8.
Xu, Qiaoling, Hong Yue, Yong Luo, et al.. (2018). Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B. Bioorganic & Medicinal Chemistry. 26(9). 2621–2631. 19 indexed citations
9.
Li, Wei & Hong Yue. (2017). Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends in Cardiovascular Medicine. 28(3). 157–171. 46 indexed citations
10.
Nweze, Emeka Innocent, Hong Yue, Liming Wang, et al.. (2016). Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53. Oncotarget. 7(19). 27430–27444. 20 indexed citations
11.
Kemp, Jacqueline, Hamiyet Ünal, Russell Desnoyer, et al.. (2014). Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin–angiotensin system. Journal of Molecular and Cellular Cardiology. 75. 25–39. 82 indexed citations
12.
Li, Xuan, et al.. (2013). Research of different effects on activity of plant antioxidant enzymes. China Journal of Chinese Materia Medica. 38(7). 973–8. 6 indexed citations
13.
Yue, Hong, Kuniyoshi Tanaka, Tatsuhiko Furukawa, Sadashiva S. Karnik, & Wěi Li. (2012). Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(8). 1316–1323. 11 indexed citations
15.
Yue, Hong, Wěi Li, Russell Desnoyer, & Sadashiva S. Karnik. (2009). Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovascular Research. 85(1). 90–99. 72 indexed citations
16.
Guo, Hangyuan, Jong‐Dae Lee, Hiroyasu Uzui, et al.. (2007). Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Canadian Journal of Cardiology. 23(4). 275–280. 8 indexed citations
18.
Yue, Hong, Hiroyasu Uzui, Hiromasa Shimizu, et al.. (2004). Different Effects of Calcium Channel Blockers on Matrix Metalloproteinase-2 Expression in Cultured Rat Cardiac Fibroblasts. Journal of Cardiovascular Pharmacology. 44(2). 223–230. 26 indexed citations
19.
Yue, Hong, Hiroyasu Uzui, Jong‐Dae Lee, Hiromasa Shimizu, & Takanori Ueda. (2004). Effects of magnesium on matrix metalloproteinase-2 production in cultured rat cardiac fibroblasts. Basic Research in Cardiology. 99(4). 257–63. 15 indexed citations
20.
Yue, Hong, Jong‐Dae Lee, Hiromasa Shimizu, et al.. (2003). Effects of magnesium on the production of extracellular matrix metalloproteinases in cultured rat vascular smooth muscle cells. Atherosclerosis. 166(2). 271–277. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026